AI-Assisted Cervical Cancer Screening

Introduction: A Partnership for Women’s Health

Prime Health Initiative Tanzania (PHIT) has established a partnership with MednTech to explore the potential of artificial intelligence (AI) to support cervical cancer screening in Tanzania. The collaboration brings together PHIT’s experience in public health research and implementation with MednTech’s work in AI-assisted screening technologies.

The partners are preparing a study to evaluate an AI-assisted screening tool within the Tanzanian healthcare context. The proposed study is currently undergoing ethical review. Implementation and data collection are anticipated to begin in early 2027, subject to ethical clearance and other relevant approvals.

Why This Work Matters

Cervical cancer prevention depends on access to screening, identification of precancerous changes, and timely treatment and follow-up. Strengthening these services remains an important priority for women’s health in Tanzania.

AI-assisted tools offer an opportunity to explore additional support for healthcare providers performing cervical screening. However, their potential value must be assessed carefully in the settings where they may eventually be used. Local evidence is essential to understand their performance, limitations, and practical implications for healthcare delivery.

What the Partnership Aims to Explore

The planned collaboration will focus on generating evidence to inform the responsible use of AI-assisted cervical screening in Tanzania. Broad areas of interest include:

• Performance in the local context: Evaluating how the investigational tool performs within Tanzanian screening services.
• Practical use in healthcare settings: Understanding provider perspectives and the conditions that could enable or constrain appropriate use.
• Evidence for future decisions: Generating findings that can inform further research and discussions about the role of AI-assisted screening.

Responsible Research and Protection of Participants

The partnership places participant safety, privacy, and ethical oversight at the centre of the proposed work. Research activities involving participants will begin only after the necessary approvals have been obtained.

The AI tool remains investigational in the proposed Tanzanian study. Clinical care will remain under the responsibility of qualified healthcare providers. Informed consent, confidentiality, and appropriate handling of health information will be central to study implementation.

The study will evaluate the technology’s potential contribution without assuming that benefits demonstrated elsewhere will necessarily translate to the Tanzanian context.

Bringing Together Public Health and Technology

MednTech is a nonprofit organisation working to improve access to preventive healthcare through technology, including AI-assisted cervical screening. Through this partnership, its technological experience will be connected with PHIT’s knowledge of local health services, digital health research, and implementation.

For PHIT, the collaboration extends its commitment to evaluating innovations that respond to local healthcare needs. It also creates an opportunity for shared learning about how emerging technologies can be assessed responsibly within existing health services.

Looking Ahead

Subject to ethical clearance and relevant approvals, PHIT and MednTech anticipate beginning implementation and data collection in early 2027. Findings from the planned work could inform further evaluation and future decisions about AI-assisted cervical cancer screening in Tanzania.

Further updates will be shared following the ethical review process and confirmation of implementation arrangements.

Learn more about MednTech at www.medntech.org.

For partnership enquiries, contact PHIT at info@phit.or.tz.